The embryonic neural crest is a unique group of cells that gives rise to the peripheral nervous system as well as many other cell types. Most of the work describing the behavior and specification of these cells has been done in the avian system, a system amenable to experimental manipulations such as tissue grafting, cell transplantation and lineage tracing. This work has been greatly facilitated by the use of molecular markers of neural crest cells such as HNK-1 and slug, markers that are not yet available for the study of mouse neural crest. Here we demonstrate that Hfh2 (HNF3 forkhead homologue 2), a member of the 'winged helix' or 'forkhead' transcription factor gene family, is expressed in premigratory and migrating neural crest cells in the early mouse embryo and in motorneuron and interneuron progenitors in the developing spinal cord. Using linkage analysis we have localized the Hfh2 gene to chromosome 4 at 44.91 cM from the centromere.
Early in the development of the nervous system, the neural plate folds to form a hollow neural tube that differentiates into the brain and spinal cord. The neural crest is a highly specialized group of cells originating in the neuroepithelium before (head neural crest) or immediately following (trunk neural crest) neural tube closure in the mouse embryo. These cells undergo an epithelial to mesenchymal transition, migrate away from the midline and then give rise to most of the peripheral nervous system including dorsal root ganglia and ganglia of the autonomic nervous system. They also differentiate into Schwann cells, pigment cells, meninges and many skeletal and connective tissues of the head and face.
During a low stringency screen of a 8.5 days post coitum (p.c.) cDNA library for homologues of the mouse winged helix (WH) transcription factor Mf3 (also known as Fkh5, HfhE5.1 and TWH; (Ang et al., 1993; Labosky et al., 1996; Kaestner et al., 1996; Dou et al., 1997) ), we identified two cDNAs corresponding to the previously identified partial rat Hfh2 (hepatocyte nuclear factor 3/forkhead homologue) cDNA (Clevidence et al., 1993) and the Xenopus laevis XFKH6 gene (Dirksen and Jamrich, 1995) . We have mapped the mouse Hfh2 gene to chromosome 4 at 44.91 cM from the centromere (±0.3 cM, confidence level of 95%) using the 1500 interspecific F1 offspring of the European Collaborative Backcross Project (European Backcross Collaborative Group, 1994) (data not shown). Recently, an apparent mouse orthologue of Hfh2 was isolated by Sutton et al. (1996) and named Genesis based on their observation of Genesis expression exclusively in embryonic stem (ES) cells or their malignant equivalent. This is in disagreement with previous work demonstrating expression of the rat Hfh2 cDNA in brain, heart, lung, liver, duodenum and kidney of adult rats (Clevidence et al., 1993) . To clarify this discrepancy, we have performed an extensive embryonic expression analysis of the mouse Hfh2 gene. The sequence of our Hfh2 cDNA matches that of Genesis, but we have elected to remain with the name Hfh2 because this was the name chosen when the gene was originally discovered.
To precisely define the expression of Hfh2 during embryogenesis, we used a combination of whole-mount and section in situ hybridization. The Hfh2 cDNA probe used did not include the DNA binding domain (WH domain) in order to eliminate the possibility of detecting cross-hybridizing mRNAs. Expression of Hfh2 in embryos at 6.5-7.5 days p.c. is uniformly distributed. However, by 8.5 days p.c., after neurulation begins, Hfh2 mRNA is restricted to the premigratory dorsal-lateral most cranial neural crest in the hindbrain and part of the midbrain except for the striking absence of staining in rhombomeres 3 and 5 (Figs. 1A-C and 2). Hfh2 expression is also pronounced in the roofplate of the neural tube caudal to the hindbrain, coincident with cells fated to become neural crest (Fig. 1B, large arrow) . In order to localize Hfh2 expression on a cellular level, we sectioned 8.5 days p.c. embryos that were previously hybridized in whole mount for Hfh2 mRNA. Fig. 1C shows a 8.5 days p.c. embryo (10 somites) with the planes of the sections in Fig. 1D -G indicated. At the mid-hindbrain level (Fig. 1D) , Hfh2 expression is restricted to two regions at the most dorsal lateral edges of the open neural folds. Further posterior in the developing spinal cord (Fig. 1E ), the neural tube is still open and Hfh2 transcripts are restricted to the edges of the neural folds. Expression is in the dorsalmost part of the spinal cord before (Fig. 1F ) and after neural tube closure. Higher magnification at the mesencephalic head fold level (Fig. 1G ) reveals that Hfh2 is expressed in the epithelial cells of the neuroepithelium (e), underlying mesenchymal cells (m) and cells undergoing an epithelial to mesenchymal transition (emt). The location of the mesenchymal cells expressing Hfh2, spread slightly beneath the neuroepithelium and dispersing ventrally, is consistent with the early distribution of midbrain-derived neural crest cells (Duband et al., 1995; Trainor and Tam, 1995) . Cranial neural crest cells expressing Hfh2 mRNA in the hindbrain persists through 9.0 days p.c. after the embryo has undergone turning (data not shown). At 9.5 days p.c., cranial neural crest cells from the mid-and hindbrain levels begin to migrate to the branchial arches, and Hfh2 mRNA is detected in cranial sensory ganglia (Fig. 1H ), the lens placode ( Fig. 1H, lp) , the lateral portion of the developing neural tube (Fig. 1I, sp) , migrating neural crest cells of the trunk (Fig. 1I, nc) , and sympathetic ganglia of the gut (Fig.  1I, sg) .
To precisely define the rhombomeric expression of Hfh2, we used a number of previously characterized molecular markers for comparison with the Hfh2 expression pattern. Krox-20 is expressed exclusively in r3 and r5 while Hoxb1 is restricted to r4 in the hindbrain (Graham et al., 1989; Wilkinson et al., 1989a) . By comparison (Fig. 2) it is clear that Hfh2 mRNA is not present in r3 and r5. Additionally, although both Hfh2 and Hoxb1 are expressed in r4, the same cells are not expressing both mRNAs (compare panels B-D). Cells expressing Hfh2 are restricted to the furthest dorsolateral cells in r4 and are not found in the remainder of the neural epithelium in this rhombomere. The same dorsolateral restriction holds true for r2 and the mesencephalic regions. To examine expression of Hfh2 in later embryos, we used radioactive in situ hybridization on sectioned embryos. Fig.  3 shows the results of our analysis at 10.5 days p.c. Panel A depicts a 10.5 days p.c. embryo with the planes of the sections in panels B-E indicated. Because the neural tube develops in a rostral to caudal progression, it is possible to analyze several stages of development in the same embryo. Fig. 3B shows a section at the forelimb bud level of the embryo with Hfh2 expression detected in several neural crest cell populations, including cells within the wall of the midgut (mg) that are the enteric nervous system precursors, future spinal ganglia (spg), and future sympathetic ganglia (sg) surrounding the aorta.
Labeled cells are also present in a restricted region of the developing spinal cord, shown at higher magnification in Fig. 3C . This pattern is detected at 9.5 days p.c. in whole mount (see Fig. 1I, sp) . The region of the spinal cord with pronounced Hfh2 expression is equivalent to a region in the E12 rat spinal cord that ultimately gives rise to motorneurons and interneurons (Altman and Bayer, 1984) . Further caudally, where the spinal cord is less mature, this same region of the neural tube does not express Hfh2 (Fig. 3D) , and expression is restricted to the migrating neural crest (nc) and the dorsal roof plate (rp) of the neural tube. In the tail region of the embryo (Fig. 3E) , only cells in the roof plate are expressing Hfh2 mRNA.
We compared the Hfh2 mRNA expression pattern to that of a series of markers of the developing spinal cord. Sections depicted in Fig. 4B -H were taken from 12.5 days p.c. embryos in the thoracic region of the body, between the forelimb and hindlimb buds. Fig. 4B shows the expression of Hfh2 is more diffuse in the spinal cord at 12.5 days p.c. than 10.5 days p.c. (Fig. 4A) . However, there is a slight concentration of signal remaining in the central region of the spinal cord that was expressing high levels of Hfh2 mRNA at 10.5 days p.c. (indicated by arrows in Fig.  4A,B) . These cells may represent the progenitors of the visceromotor column whose neurons arise together with the somatic motorneuron population. Differentiating somatic motor neurons, as marked by the expression of cret, Islet-1 and Mf3 (Fig. 4C-E) , are restricted to a more ventral and lateral position than Hfh2 expressing cells. By comparison, expression of the dorsally restricted Pax3 mRNA (Panel F) reveals that Hfh2 expressing cells mark the ventral extent of this dorsal marker (compare the placement of the arrow in Fig. 4B,E) . Similarly, Hfh2 expression Pax3, green; Mf3, red; blue; orange; En1, aqua; and Pax6, pink. drg, dorsal root ganglion; ep, ependymal cells; mn, motorneurons. is ventral to the cells expressing En1 (Fig. 4G) and Pax6 (Fig. 4H) . Fig. 4I is a composite summarizing the distribution of all markers analyzed in the 12.5 days p.c. spinal cord. Hfh2 expression is indicated in purple with the slight concentration seen clearest at 10.5 days p.c. (Figs. 3B,C and 4A) indicated in solid purple and the more diffuse staining over the region of the differentiating somatic motor neurons in speckled purple.
We have described here the cloning of the cDNA for the mouse gene Hfh2, documented the Hfh2 expression pattern in the developing mouse embryo and described its chromosomal localization. The expression of Hfh2 in the premigratory and migrating neural crest cells makes it, along with the monoclonal antibody 4E9R (Kubota et al., 1996) , one of the first molecular markers of the murine premigratory neural crest. The neural crest expression of the mouse Hfh2 gene is analogous to the restricted expression of the Xenopus XFKH6 gene in the neural crest cells (Dirksen and Jamrich, 1995) , further supporting the idea that these genes are orthologues.
Methods

cDNA Cloning
An embryonic mouse 8.5 days p.c. cDNA library (Kaestner et al., 1995) was screened with a 1 kb fragment of the mouse Mf3 cDNA using low-stringency hybridization and washing conditions (Church and Gilbert, 1984) . The complete sequence has been deposited in the GenBank database under accession number AF067421.
In situ hybridization
Mouse embryos were obtained from matings between CD1 mice (Charles River Laboratories). By convention, noon on the day of the vaginal plug was counted as 0.5 days p.c. For whole-mount and section in situ hybridization, embryos were processed as described (Wilkinson, 1992; Hogan et al., 1994) . A 874 bp fragment of Hfh2 (positions 1431 to 2305 of the cDNA) which excludes the WH DNA binding motif served as template for both antisense probe and sense control.
Probes for whole mount in situs were labeled with digoxigenin-UTP and for hybridizations of embryo sections with [ 33 P]UTP (Amersham). The probes used have been described as follows: c-ret (Pachnis et al., 1993) , En-1 (Davis and Joyner, 1988) , Hoxb1 (Wilkinson et al., 1989b) , Islet1 (Thor et al., 1991) , Mf3 (Labosky et al., 1997) , Pax3 (Goulding et al., 1991) , and Pax6 (Grindley et al., 1995) . Slides were dipped in Amersham LM-1 emulsion, exposed for 1 week and developed using Kodak D19 developing solution and Kodafix at 15°C for 4 min. Sections were stained using eosin and hematoxylin, and visualized using a Nikon E600 microscope with a Darklite illuminator (Micro Video Instruments).
